Zdenek Antal

Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry

J. Sevcík, H. Bučková, M. Tichý, 2023, Dermatology and Therapy.

Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic

J. Sevcík, J. Štork, M. Tichý, 2021, Dermatology and Therapy.